Improving delivery of treatments to the vocal folds for voice disorders
Pharmacological Approaches for Transepithelial Delivery of Therapeutics to the Vocal Folds
This study is looking at new ways to deliver medicine directly to the vocal folds to help people with voice disorders, aiming to find safer and more effective treatments that can improve their voice health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Saint Louis University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11061229 on NIH RePORTER |
What this research studies
This research investigates how to effectively deliver therapeutic agents directly to the vocal folds, which are crucial for voice production. The approach focuses on using pharmacological methods to enhance the permeability of vocal fold tissues, allowing for better absorption of medications. By studying the cellular and molecular mechanisms involved, the research aims to identify safe and effective treatments for individuals suffering from voice disorders. Patients may benefit from improved therapies that target the underlying causes of their vocal issues.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults experiencing voice disorders, including dysphonia, who may benefit from enhanced therapeutic delivery methods.
Not a fit: Patients with voice disorders not related to the vocal folds or those who are under 21 years old may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for voice disorders, improving quality of life for many patients.
How similar studies have performed: Other research has shown promise in using pharmacological approaches for targeted delivery of treatments, suggesting potential success for this investigation.
Where this research is happening
Saint Louis, United States
- Saint Louis University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Rousseau, Bernard — Saint Louis University
- Study coordinator: Rousseau, Bernard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.